SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Arthur Radley who wrote (7281)9/23/1998 1:35:00 PM
From: LarryS  Read Replies (2) of 17367
 
There is something here that is not adequately explained in
the FAQ and that is the purpose of the final review.
Would XOMA/DSMB (for positive PR reasons)
review just before the end of the trial and at that time
recommend termination of Phase III and then use
it open label (instead of 50% placebos) during the meno season
in late winter?? Could they do that without FDA approval?

I thought the trial was to be over in December so a review
in November would only save about 30 days...so what??
There is something here we are not being told or do not
understand.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News